NanoViricides Inc. (NNVC)

[JG36]

Your calculation assumes no increase in the number of shares between now and then. I think that's very optimistic. Oh, if only every start up I invested in never had to issue new shares! How rich I'd be!

From Dr Diwan, via Dr. Seymour:

"I estimate that we could charge at least $2200/dose (hopefully only one dose needed) which is what HHS paid Peramivir for its drug that didn't work (under Emergency Use Authorization) during the 2009-10 flu emergency. Because of the DRG payment system, either after US approval or under compassionate use authorization, I think we could charge as much as $5000/dose ..."

So NNVC will charge what the market will bear, just like all those big bad pharmaceutical companies do.